REGISTERED
on 13 Nov 2018
Last Applicant/ Owned by
King Charles House,
GB
Serial Number
79208607 filed on 15th Dec 2016
Registration Number
5603613 registered on 13th Nov 2018
Correspondent Address
Susan Piasick Christoff
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
E
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medica Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
Class [005]
Pharmaceutical Products
Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for transport of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes that deliver protein for genetic therapy; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle-based nucleic acid therapeutics for the prevention and treatment of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders
Mark Details
Serial Number
No 79208607
Mark Type
No Service Mark
Attorney Docket Number
No 328109-20006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 04th Dec 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 30th Jul 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| 08th Mar 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 20th Feb 2019 | FINAL DISPOSITION PROCESSED |
| 20th Feb 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| 13th Feb 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 13th Nov 2018 | REGISTERED-PRINCIPAL REGISTER |
| 28th Aug 2018 | PUBLISHED FOR OPPOSITION |
| 28th Aug 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |